- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有59家主力机构披露2026-06-30报告期持股数据，持仓量总计3.03亿股，占流通A股30.40%
- 波段诊断：
-
技术面诊股
诊断结果：4.6技术面打败了37%的股票
技术面评分前10的股票
近期的平均成本为0.00元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为0.00元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"0.00","date":1793692981,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2026.11.04","stock":"1.08","trade":null,"ind":"4.22"},{"date":"2026.11.03","stock":"0.91","trade":null,"ind":"-1.21"},{"date":"2026.11.02","stock":"1.48","trade":null,"ind":"1.63"},{"date":"2026.10.30","stock":"-0.55","trade":null,"ind":"-2.73"},{"date":"2026.10.29","stock":"-1.45","trade":null,"ind":"-2.92"},{"date":"2026.10.28","stock":"2.03","trade":null,"ind":"2.02"},{"date":"2026.10.27","stock":"-5.91","trade":null,"ind":"-2.50"},{"date":"2026.10.26","stock":"1.23","trade":null,"ind":"-1.19"},{"date":"2026.10.23","stock":"-2.07","trade":null,"ind":"2.79"},{"date":"2026.10.22","stock":"-4.76","trade":null,"ind":"-2.96"},{"date":"2026.10.21","stock":"-0.98","trade":null,"ind":"-0.82"},{"date":"2026.10.20","stock":"-2.23","trade":null,"ind":"-0.14"},{"date":"2026.10.19","stock":"-1.72","trade":null,"ind":"0.13"},{"date":"2026.10.16","stock":"-1.69","trade":null,"ind":"-0.12"},{"date":"2026.10.15","stock":"0.00","trade":null,"ind":"-2.43"},{"date":"2026.10.14","stock":"-1.06","trade":null,"ind":"-1.97"},{"date":"2026.10.13","stock":"1.86","trade":null,"ind":"-0.25"},{"date":"2026.10.12","stock":"-4.86","trade":null,"ind":"-2.03"},{"date":"2026.10.09","stock":"3.19","trade":null,"ind":"0.17"},{"date":"2026.10.08","stock":"4.11","trade":null,"ind":"-2.07"},{"date":"2026.09.30","stock":"3.61","trade":null,"ind":"-0.11"}]
蓝帆医疗,深证成指,医疗器械指数
压力支撑
该股压力位为5.57元，支撑位为5.50元。
[{"text":"\u538b\u529b\u4f4d","value":"5.57","date":1793721600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.50","date":1793721600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.8资金面打败了51%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：11月04日 20:30
| 机构今日流向(万元) | 810.55 | 机构5日流向(万元) | 1474.89 |
| 机构10日流向(万元) | 4138.06 | 机构20日流向(万元) | 2658.86 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量增加1357.39万股，其中基金净增仓7家，主力净增仓21家，有一定的中长期投资价值。
截止2026-06-30，共59家主力机构（基金54家，一般法人5家），持仓量总计30328.92万股，占流通A股30.40%
其中，基金持仓与2025-12-31相比：
增仓：12家 ，增持 137.78万股
减仓：5家 ，减持 7.28万股
新出现在主力名单中：38家 ，持有2093.72万股
从主力名单中消失：17家 ，原持有2301.64万股
其中，基金持仓与2025-12-31相比：
增仓：12家 ，增持 137.78万股
减仓：5家 ，减持 7.28万股
新出现在主力名单中：38家 ，持有2093.72万股
从主力名单中消失：17家 ，原持有2301.64万股
消息面诊股
诊断结果：5.7消息面打败了18%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 蓝帆医疗：11月3日获融资买入687.56万元
2026-11-04 - A股医疗器械三季报：超七成企业营收增长，十强营收8
2026-11-03 - 第八届国际医用机器人创新发展论坛在京成功举办
2026-11-03 - 蓝帆医疗刘文静董事长当选淄博市企业和企业家联合会医
2026-11-03 - 20药企密集“补税” 以短期阵痛换长期合规
2026-11-03 - 蓝帆医疗：10月30日获融资买入526.64万元
2026-11-02 - 蓝帆医疗全新北京平台正式投用
2026-10-30 - 从规模扩张转向价值创造-医疗器械行业发展趋势展望
2026-10-29 - 蓝帆医疗：北京蓝帆柏盛医疗科技股份有限公司是公司心
2026-10-28 - 蓝帆医疗最新股东户数环比下降5.64% 筹码趋向集
2026-10-27
消息列表
| 一般消息 | 募资投向 | 公司出售资产 | 2026-09-24 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-09-24 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-09-01 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-25 |
| 一般消息 | 高管变动 | 股权转让带来的股权结构、管理架构统... | 2026-08-18 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-08-18 |
| 利好 | 业绩预告 | 预计扭亏 | 2026-07-15 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-06-06 |
| 一般消息 | 重大事项 | 关联交易 | 2026-05-23 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-29 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-29 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-29 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-03-13 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-03-13 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-13 |
| 重大利空 | 业绩预告 | 预计增亏 | 2026-01-31 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-13 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-13 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：3.5行业面打败了58%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2026.11.04","price":"4.22","value":null},{"date":"2026.11.03","price":"-1.21","value":null},{"date":"2026.11.02","price":"1.63","value":null},{"date":"2026.10.30","price":"-2.73","value":null},{"date":"2026.10.29","price":"-2.92","value":null},{"date":"2026.10.28","price":"2.02","value":null},{"date":"2026.10.27","price":"-2.50","value":null},{"date":"2026.10.26","price":"-1.19","value":null},{"date":"2026.10.23","price":"2.79","value":null},{"date":"2026.10.22","price":"-2.96","value":null},{"date":"2026.10.21","price":"-0.82","value":null},{"date":"2026.10.20","price":"-0.14","value":null},{"date":"2026.10.19","price":"0.13","value":null},{"date":"2026.10.16","price":"-0.12","value":null},{"date":"2026.10.15","price":"-2.43","value":null},{"date":"2026.10.14","price":"-1.97","value":null},{"date":"2026.10.13","price":"-0.25","value":null},{"date":"2026.10.12","price":"-2.03","value":null},{"date":"2026.10.09","price":"0.17","value":null},{"date":"2026.10.08","price":"-2.07","value":null},{"date":"2026.09.30","price":"-0.11","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 健帆生物 | 28.36% | 17.37% | 6.5分 |
| 2 | 新产业 | 20.81% | 4.50% | 6.4分 |
| 3 | 三诺生物 | 14.97% | 0.92% | 6.6分 |
| 4 | 安图生物 | 14.26% | 2.07% | 6.1分 |
| 5 | 振德医疗 | 13.08% | 4.68% | 6.2分 |
| 6 | 迈瑞医疗 | 12.20% | 3.25% | 6.8分 |
| 8 | 开立医疗 | 11.17% | 0.14% | 5.8分 |
| 10 | 威高血净 | 9.94% | 12.68% | 6.4分 |
| 12 | 联影医疗 | 9.56% | 4.15% | 6.0分 |
| 14 | 乐普医疗 | 8.78% | 3.39% | 6.1分 |
| 16 | 正川股份 | 6.45% | 4.48% | 4.6分 |
| 18 | 三鑫医疗 | 5.64% | 2.14% | 6.3分 |
| 20 | 欧普康视 | 5.04% | 2.91% | 5.4分 |
| 22 | 微电生理 | 3.46% | -0.84% | 5.2分 |
| 24 | 佰仁医疗 | 3.15% | -1.24% | 5.0分 |
| 26 | 阳普医疗 | 2.60% | 18.73% | 5.6分 |
| 28 | ST凯利 | 1.77% | -1.56% | 5.0分 |
| 30 | 理邦仪器 | 1.63% | 0.51% | 6.0分 |
| 32 | 迈普医学 | -0.48% | -0.19% | 5.7分 |
| 34 | 万东医疗 | -1.04% | -0.10% | 5.2分 |
| 36 | 南微医学 | -1.46% | 6.78% | 5.8分 |
| 38 | ST迪瑞 | -1.55% | -3.86% | 4.0分 |
| 40 | 可孚医疗 | -1.80% | -4.55% | 5.4分 |
| 42 | 康众科技 | -2.50% | 1.40% | 5.2分 |
| 44 | 健尔康 | -3.04% | 0.33% | 5.1分 |
| 46 | 美康生物 | -3.51% | -1.49% | 5.7分 |
| 48 | 天智航 | -3.84% | -10.69% | 4.9分 |
| 50 | 健信超导 | -4.12% | 3.50% | 5.9分 |
| 52 | 南卫股份 | -4.26% | 2.28% | 4.5分 |
| 54 | 康德莱 | -4.74% | 1.40% | 4.7分 |
| 56 | 迈克生物 | -4.93% | -2.58% | 4.7分 |
| 58 | 威高骨科 | -5.02% | -6.99% | 3.8分 |
| 60 | 澳华内镜 | -5.62% | -4.91% | 5.0分 |
| 62 | 拱东医疗 | -5.77% | -2.50% | 5.0分 |
| 64 | 春立医疗 | -6.25% | -0.15% | 4.5分 |
| 66 | - | -6.75% | -0.28% | 分 |
| 68 | 博拓生物 | -6.87% | -1.86% | 4.1分 |
| 70 | 华强科技 | -7.21% | -6.88% | 3.4分 |
| 72 | 三友医疗 | -7.92% | -6.79% | 4.0分 |
| 74 | 艾德生物 | -8.29% | -2.73% | 5.1分 |
| 76 | 安旭生物 | -8.91% | -4.37% | 3.4分 |
| 78 | 赛诺医疗 | -9.68% | -0.52% | 5.2分 |
| 80 | 凯普生物 | -9.81% | -5.16% | 4.1分 |
| 82 | - | -10.00% | 0.19% | 分 |
| 84 | 九安医疗 | -10.40% | 3.62% | 5.5分 |
| 86 | 国发股份 | -10.65% | -1.61% | 4.3分 |
| 88 | 伟思医疗 | -10.79% | -5.06% | 3.8分 |
| 90 | 黄山胶囊 | -10.88% | -1.78% | 4.8分 |
| 92 | 西山科技 | -11.14% | -5.02% | 3.4分 |
| 94 | *ST益通 | -11.33% | 1.66% | 4.1分 |
| 96 | 东星医疗 | -11.43% | 1.56% | 5.3分 |
| 98 | 正海生物 | -11.86% | -1.13% | 4.5分 |
| 100 | 济高发展 | -11.94% | -1.67% | 4.8分 |
| 102 | 尚荣医疗 | -12.61% | -1.00% | 4.6分 |
| 104 | - | -12.76% | 2.24% | 分 |
| 106 | 易瑞生物 | -13.23% | -4.31% | 4.0分 |
| 108 | 康拓医疗 | -13.41% | -5.15% | 4.1分 |
| 110 | 瑞迈特 | -13.81% | -9.60% | 4.4分 |
| 112 | 基蛋生物 | -14.09% | -1.26% | 4.8分 |
| 114 | 乐心股份 | -14.77% | 0.00% | 4.6分 |
| 116 | 济民健康 | -15.74% | -6.21% | 3.8分 |
| 118 | 宝莱特 | -15.98% | 3.92% | 5.2分 |
| 120 | 硕世生物 | -16.96% | -1.93% | 4.1分 |
| 122 | 爱威科技 | -17.74% | -3.91% | 4.6分 |
| 124 | 五洲医疗 | -18.32% | -16.33% | 4.1分 |
| 126 | 赛科希德 | -18.77% | -4.90% | 4.2分 |
| 128 | 仁度生物 | -19.70% | -3.83% | 4.2分 |
| 130 | 康为世纪 | -21.52% | -6.09% | 4.1分 |
| 132 | 华兰股份 | -24.28% | -6.93% | 4.8分 |
| 134 | 浩欧博 | -24.54% | -4.08% | 4.4分 |
| 136 | 采纳股份 | -25.68% | -5.42% | 4.2分 |
| 138 | 热景生物 | -26.96% | -3.90% | 4.0分 |
| 140 | 海泰新光 | -29.58% | -3.44% | 4.7分 |
| 142 | 奥精医疗 | -56.47% | -49.54% | 3.4分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 国都证券 | 2012-09-11 | 中性 | 增持 |
| 民族证券 | 2012-09-11 | 增持 | - |
| 长城证券 | 2012-09-10 | 中性 | 中性 |
| 民生证券 | 2012-09-10 | 中性 | 中性 |
| 东北证券 | 2012-09-10 | 中性 | 中性 |
更多>>行业资讯
- 2012-09-13ST联华重大诉讼进展情况
- 2012-09-13*ST黄海参加青岛辖区上市公司投资者网上集体接待日
- 2012-09-13骆驼股份签署募集资金专户存储四方监管协议
- 2012-09-13雷鸣科化中国证监会审核公司重大资产重组停牌
- 2012-09-13S仪化本公司股改进展的风险提示
- 2012-09-13亚星化学控股股东股权解除冻结
- 2012-09-13沃尔核材：向全资子公司香港沃尔贸易有限公司增资
- 2012-09-13超日太阳：子公司超日洛阳取得实用新型专利证书
- 2012-09-13神剑股份：对外提供财务资助
- 2012-09-13江南化工：公司申请发行短期融资券
基本面诊股
[ 截止日期：2026-09-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 82/243 ， 112/243。
[{"date":"2026-09-30","value":"2.15","vol":"3.55"},{"date":"2026-06-30","value":"1.34","vol":"2.35"},{"date":"2026-03-31","value":"0.01","vol":"1.12"},{"date":"2025-12-31","value":"-9.89","vol":"2.37"},{"date":"2025-09-30","value":"-3.56","vol":"3.06"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.15 | 1.34 | 0.01 | -9.89 | -3.56 |
| 行业(%) | 3.55 | 2.35 | 1.12 | 2.37 | 3.06 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"27.63","vol":"52.26"},{"date":"2026-06-30","value":"29.72","vol":"52.38"},{"date":"2026-03-31","value":"25.02","vol":"52.12"},{"date":"2025-12-31","value":"15.67","vol":"51.82"},{"date":"2025-09-30","value":"13.66","vol":"52.03"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
27.63 | 29.72 | 25.02 | 15.67 | 13.66 |
| 行业(%) | 52.26 | 52.38 | 52.12 | 51.82 | 52.03 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 13/243 ， 11/243。
[{"date":"2026-09-30","value":"28.88","vol":"7.31"},{"date":"2026-06-30","value":"29.67","vol":"5.46"},{"date":"2026-03-31","value":"6.33","vol":"5.59"},{"date":"2025-12-31","value":"-8.21","vol":"1.01"},{"date":"2025-09-30","value":"-10.15","vol":"0.11"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
28.88 | 29.67 | 6.33 | -8.21 | -10.15 |
| 行业(%) | 7.31 | 5.46 | 5.59 | 1.01 | 0.11 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"160.88","vol":"-76.55"},{"date":"2026-06-30","value":"179.72","vol":"-24.55"},{"date":"2026-03-31","value":"-98.84","vol":"-20.93"},{"date":"2025-12-31","value":"-70.32","vol":"-33.44"},{"date":"2025-09-30","value":"-30.09","vol":"-15.21"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
160.88 | 179.72 | -98.84 | -70.32 | -30.09 |
| 行业(%) | -76.55 | -24.55 | -20.93 | -33.44 | -15.21 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 28/243 ， 7/243。
[{"date":"2026-09-30","value":"0.35","vol":"0.26"},{"date":"2026-06-30","value":"0.23","vol":"0.17"},{"date":"2026-03-31","value":"0.10","vol":"0.08"},{"date":"2025-12-31","value":"0.34","vol":"0.35"},{"date":"2025-09-30","value":"0.25","vol":"0.25"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.35 | 0.23 | 0.10 | 0.34 | 0.25 |
| 行业(次) | 0.26 | 0.17 | 0.08 | 0.35 | 0.25 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"3.61","vol":"1.68"},{"date":"2026-06-30","value":"2.35","vol":"1.12"},{"date":"2026-03-31","value":"1.09","vol":"0.55"},{"date":"2025-12-31","value":"4.12","vol":"2.33"},{"date":"2025-09-30","value":"3.01","vol":"1.66"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
3.61 | 2.35 | 1.09 | 4.12 | 3.01 |
| 行业(次) | 1.68 | 1.12 | 0.55 | 2.33 | 1.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-09-30","value":"15.65","vol":"12.33"},{"date":"2026-06-30","value":"16.74","vol":"14.81"},{"date":"2026-03-31","value":"4.45","vol":"-0.33"},{"date":"2025-12-31","value":"14.79","vol":"32.14"},{"date":"2025-09-30","value":"-7.70","vol":"14.86"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 15.65 | 16.74 | 4.45 | 14.79 | -7.70 |
| 行业 | 12.33 | 14.81 | -0.33 | 32.14 | 14.86 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"","vol":"0.00"},{"date":"2026-06-30","value":"0.76","vol":"1.31"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.94","vol":"1.62"},{"date":"2025-09-30","value":"","vol":"0.01"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.76 | - | 0.94 | - |
| 行业 | 0.00 | 1.31 | 0.00 | 1.62 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 44/243 ， 23/243。
[{"date":"2026-09-30","value":"0.92","vol":"5.51"},{"date":"2026-06-30","value":"0.91","vol":"5.78"},{"date":"2026-03-31","value":"0.87","vol":"6.17"},{"date":"2025-12-31","value":"0.85","vol":"5.27"},{"date":"2025-09-30","value":"0.87","vol":"5.64"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.92 | 0.91 | 0.87 | 0.85 | 0.87 |
| 行业 | 5.51 | 5.78 | 6.17 | 5.27 | 5.64 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"0.61","vol":"4.40"},{"date":"2026-06-30","value":"0.62","vol":"4.71"},{"date":"2026-03-31","value":"0.62","vol":"5.04"},{"date":"2025-12-31","value":"0.59","vol":"4.13"},{"date":"2025-09-30","value":"0.58","vol":"4.49"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.61 | 0.62 | 0.62 | 0.59 | 0.58 |
| 行业 | 4.40 | 4.71 | 5.04 | 4.13 | 4.49 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 18/243 ， 14/243。
[{"date":"2026-09-30","value":"36.60","vol":"23.57"},{"date":"2026-06-30","value":"38.50","vol":"23.17"},{"date":"2026-03-31","value":"41.62","vol":"22.26"},{"date":"2025-12-31","value":"43.56","vol":"23.19"},{"date":"2025-09-30","value":"41.01","vol":"22.23"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
36.60 | 38.50 | 41.62 | 43.56 | 41.01 |
| 行业(%) | 23.57 | 23.17 | 22.26 | 23.19 | 22.23 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"0.73","vol":"0.43"},{"date":"2026-06-30","value":"0.84","vol":"0.42"},{"date":"2026-03-31","value":"0.95","vol":"0.40"},{"date":"2025-12-31","value":"1.02","vol":"0.41"},{"date":"2025-09-30","value":"0.85","vol":"0.72"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.73 | 0.84 | 0.95 | 1.02 | 0.85 |
| 行业(%) | 0.43 | 0.42 | 0.40 | 0.41 | 0.72 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"-3.72","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-5.68","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-4.46","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-7.59","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]